PharmTech Drug Digest 11.20

Whitepapers


All series


All Whitepapers

Sponsored Content

Simple Plex™ Assays on Ella™ are hands-free, fast and reproducible immunoassays that eliminate all manual steps of traditional ELISAs. In this application note, we pair Ella with the industry leading Cygnus Technologies 3G CHO antibodies to bring you superior assay sensitivity and data reproducibility throughout the manufacturing process.

Sponsored Content

Tablet hardness is essential when formulating a solid dosage form. Certain combinations of commonly used excipients may lead to softer tablets. This study outlines how to avoid those pitfalls and learn which excipients will enhance compaction.

Sponsored Content

Myths and misunderstanding abound when it comes to microbiology. When it comes to cleanroom and pharmaceutical microbiology, some “myths” have become engrained and even endorsed by regulatory bodies. The authors use logic and sound science to dispel some Microbiological Myths related to Disinfectant Cleaning of Controlled Environments.

Sponsored Content

Identifying counterfeit drugs has become an area of increasing focus for regulatory authorities and also for pharmaceutical companies. Raman spectroscopy is highly specific and can differentiate between materials with similar chemical structures.

Sponsored Content

-Micronization improves API bioavailability in new chemical entities. -Increased market demand for micronization has sparked increased CMO services. -Lonza Engine™ provides advantages throughout the drug development process.

PharmTech Sponsored eBooks

Bioassays are critical for assessing potency and biological activity during biopharmaceutical activity, but they must be carefully designed to ensure reliability. Learn about new developments in cell-based bioassays and binding assays.

Sponsored Content

This paper describes the existing regulatory framework for combined products and focuses on stability testing to assess drug or biological-device compatibility.

PharmTech Sponsored eBooks

A core challenge among drug developers is working with challenging APIs, which are increasingly becoming more hydrophobic and/or with stronger crystal lattice structures, each ultimately poorly water soluble. This ebook covers a variety of important tools for formulators.

Sponsored Content

* Differentiate the suitability, quality and processability of an excipient. * Recognize the significant impact of superior excipient processability. * Understand the economic return associated with excipient selection.